The Lancet Digital Health

The Lancet Digital Health is a monthly peer-reviewed specialty journal published by Elsevier as part of The Lancet Group, launched in 2019 and covering digital health and the application of technology in clinical medicine, public health and global health, with a 2025 Journal Impact Factor of 25.5《柳叶刀：数字健康》是由（Elsevier）作为柳叶刀集团（The Lancet Group）一员出版、2019 年创刊的月刊同行评审专科期刊，涵盖数字健康以及技术在临床医学、公共卫生与全球健康中的应用，2025 年影响因子为 25.5。

Scope

• It publishes high-quality original research, candid commentary and correspondence that promote digital technologies in health practice worldwide该刊刊载高质量的原创研究、坦诚的评论与通讯，推动数字技术在全球医疗实践中的应用。
• The journal publishes important, innovative and practice-changing research on any topic connected with digital technology in clinical medicine, public health and global health该刊刊载与临床医学、公共卫生及全球健康中数字技术相关的任何主题的重要、创新且改变实践的研究。
• Its scope spans artificial intelligence and machine learning in health care, digital diagnostics and imaging and health informatics其范围涵盖医疗中的人工智能与机器学习、数字诊断与影像以及健康信息学。
• It covers telehealth and remote monitoring, wearable devices and sensors and mobile health applications该刊涵盖远程医疗与远程监测、可穿戴设备与传感器以及移动健康应用。
• It addresses electronic health records, real-world data and the ethics, regulation and equity of digital health该刊关注电子健康记录、真实世界数据，以及数字健康的伦理、监管与公平性。
• It serves the digital health, clinical and wider health communities by promoting high-quality science and supporting the ethical use of technologies and data in practice该刊通过推动高质量科学、支持技术与数据在实践中的负责任使用，服务于数字健康界、临床界及更广泛的健康群体。

History

• It was launched in 2019 and published its first issue in May 2019, Volume 1, Issue 1, accompanied by a launch editorial that set out its cross-disciplinary mission该刊于 2019 年创刊，首期于 2019 年 5 月以第 1 卷第 1 期出版，并配以一篇阐明其跨学科使命的创刊社论。^[1]
• It was founded as a specialty title within The Lancet Group and quickly became the leading journal in medical informatics该刊作为柳叶刀集团旗下的专科刊创办，并迅速成为医学信息学领域排名第一的期刊。
• Its founding Editor-in-Chief was Rupa Sarkar, who led the journal from launch until she left in 2026其创刊主编为 Rupa Sarkar，她自创刊起执掌该刊，直至 2026 年离任。
• The journal forms part of the wider Lancet family of specialty journals, which spans oncology, respiratory medicine, rheumatology, public health and more该刊隶属更广泛的柳叶刀专科期刊家族，该家族涵盖肿瘤学、呼吸医学、风湿病学、公共卫生等方向。
• Its 2025 Journal Impact Factor is 25.5, up from 24.1 in 2024, ranking first among 54 medical informatics journals其 2025 年影响因子为 25.5，高于 2024 年的 24.1，在 54 种医学信息学期刊中排名第一。

Editors

• The current Editor-in-Chief is Hugh Thomas, who took up the role in 2026 after serving as Deputy Editor of The Lancet Gastroenterology & Hepatology现任主编为 Hugh Thomas，他于 2026 年就任，此前担任（The Lancet Gastroenterology & Hepatology）副主编。^[2]
• He previously studied medical genetics at Swansea University and the developmental origins of metabolic disease at the University of Southampton他此前在（Swansea University）研习医学遗传学，并在（University of Southampton）研究代谢疾病的发育起源。
• The journal is part of The Lancet Group, whose Editor-in-Chief is Richard Horton of The Lancet该刊隶属柳叶刀集团，集团主编为（The Lancet）的 Richard Horton。
• Its content is peer reviewed by external experts and managed by an in-house editorial team supported by an international advisory board其内容由外部专家同行评审，并由全职编辑团队在国际顾问委员会支持下管理。
• Its editorial mission emphasizes practice-changing research and the responsible, ethical use of health data and technologies其编辑宗旨强调改变实践的研究，以及健康数据与技术的负责任、合乎伦理的使用。